ProofPilot Online App (https://p.proofpilot.com)
New York, 10003, United States
NCT Number: NCT04393961
Radish Health and ProofPilot in coordination with Sanesco are running this study to help establish whether the Premier Biotech COVID-19 IgG/IgM Rapid Test Cassette (Whole Blood/Serum/Plasma Authorized for distribution under emergency use authorization - though not yet FDA reviewed) can be conducted effectively at home to detect COVID-19 antibodies among individuals who have tested positive, or suspect they have previous contracted from COVID-19 and recovered. The study also aims to examine how the results of those tests change social-distancing behaviors and general anxiety over 8 weeks post-test.
Looking for future studies?
Notify Me18 year–100 year
All sexes
Interventional
Not applicable
New York, 10003, United States
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Current emergency situation, there are large numbers of COVID-19 Antibody tests being made available at a record pace.
The protocol is designed to be test agnostic. However, for this first volley, we have chosen the The COVID-19 IgG and IgM Rapid Test provided by Premier Biotech.
We chose the Precision Bio test for 4 reasons
Time frame: Day 0
Comparison of participant reported self-test result vs physician review of self-test results via participant reported photograph of the test
Time frame: Day 0
Mesure of participant self report on ease of test administration via a custom survey assessment
Time frame: Week 8
Change in Actual vs Anticipated social distancing behavior as measured by modified PROMIS Satisfaction with Social Questionnaire.
Time frame: Week 8
Change in economic, personal and other anxiety triggers as measured by a modified version of the Zung Self-Rating Anxiety Scale.
ProofPilot
Industry
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT04865237
COVID-19, Corona Virus Infection
London, United Kingdom
View Trial DetailsNCT04363268
COVID, COVID-19
Palo Alto, California, United States
View Trial DetailsNCT04721457
COVID-19, Coronaviridae Infections
Jeddah, Saudi Arabia
View Trial DetailsNCT04483973
COVID-19, Corona Virus Infection
New Haven, Connecticut, United States
View Trial Details